However, upregulation of DCAF7 decreased the cisplatin sensitivity of NPC cells, as evidenced by the higher IC50 value, reduced apoptosis, lower levels of cleaved caspase 3 and caspase 9, and fewer TUNEL‐positive cells following cisplatin treatment (Figure S2F–H, Supporting Information). The gene discussed is DCAF7; the disease is nasopharyngeal carcinoma.